The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
Diabetic Retinopathy: Vascular and Inflammatory Disease
Open accessAbstract
Diabetic retinopathy (DR) is the leading cause of visual impairment in the working-age population of the Western world. The pathogenesis of DR is complex and several vascular, inflammatory, and neuronal mechanisms are involved. Inflammation mediates structural and molecular alterations associated with DR. However, the molecular mechanisms underlying the inflammatory pathways associated with DR are not completely characterized. Previous studies indicate that tissue hypoxia and dysregulation of immune responses associated with diabetes mellitus can induce increased expression of numerous vitreous mediators responsible for DR development. Thus, analysis of vitreous humor obtained from diabetic patients has made it possible to identify some of the mediators (cytokines, chemokines, and other factors) responsible for DR pathogenesis. Further studies are needed to better understand the relationship between inflammation and DR. Herein the main vitreous-related factors triggering the occurrence of retinal complication in diabetes are highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Investigative Ophthalmology and Visual Science
Frey, C. (2010) · Cited by 3,350
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1594 · Cited by 2,487
Jonjić, S., Mutter, W., Weiland, F., Reddehase, M. J., & Koszinowski, U. H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1199 · Cited by 2,105
Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961 · cited 1×
“Hyperglycemia is the main culprit in DR development; it affects the levels of plasma cytokines (TNF-α and IL-6) implicated in insulin resistance [26].”
BackgroundCarmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., et al. (2001) · Nature Medicine · doi:10.1038/87904 · Cited by 1,672
Aggarwal, B. B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.003 · Cited by 1,574
Signaling in innate immunity and inflammation
Newton, K., & Dixit, V. M. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006049 · Cited by 1,513 · cited 2×
“[33] K.”
BackgroundTumor Necrosis Factor-α Signaling in Macrophages
Parameswaran, N., & Patial, S. (2010) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v20.i2.10 · Cited by 1,437
The role of cyclooxygenases in inflammation, cancer, and development
Williams, C. S., Mann, M., & DuBois, R. N. (1999) · Oncogene · doi:10.1038/sj.onc.1203286 · Cited by 1,417
Inflammatory cytokines in vascular dysfunction and vascular disease
Sprague, A. H., & Khalil, R. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.029 · Cited by 1,352
Adamis, A. P., Miller, J. W., Bernal, M.-T., D'Amico, D. J., Folkman, J., Yeo, T.-K., & Yeo, K.-T. (1994) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)75794-0 · Cited by 1,296
Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation
Kubota, N., Terauchi, Y., Yamauchi, T., Kubota, T., Moroi, M., Matsui, J., Eto, K., Yamashita, T., Kamon, J., Satoh, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200251200 · Cited by 1,208
A central role for inflammation in the pathogenesis of diabetic retinopathy
Joussen, A. M., Poulaki, V., Le, M. L., Koizumi, K., Esser, C., Janicki, H., Schraermeyer, U., Kociok, N., Fauser, S., Kirchhof, B., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-1476fje · Cited by 1,176
Disruption of adiponectin causes insulin resistance and neointimal formation
Froguel, P. (2002) · HAL · Cited by 1,134
Inflammation in diabetic retinopathy
Tang, J., & Kern, T. S. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.05.002 · Cited by 1,116
Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia
Levy, A. P., Levy, N. S., Wegner, S., & Goldberg, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13333 · Cited by 1,067
Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor
Cohen, T., Nahari, D., Cerem, L. W., Neufeld, G., & Levi, B.-Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.736 · Cited by 1,039
IL-1 is required for tumor invasiveness and angiogenesis
Voronov, E., Shouval, D. S., Krelin, Y., Cagnano, E., Benharroch, D., Iwakura, Y., Dinarello, C. A., & Apte, R. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437939100 · Cited by 1,023
Chiquet-Ehrismann, R., Mackie, E. J., Pearson, C. A., & Sakakura, T. (1986) · Cell · doi:10.1016/0092-8674(86)90374-0 · Cited by 992
Takahashi, H., & Shibuya, M. (2005) · Clinical Science · doi:10.1042/cs20040370 · Cited by 953
Digicaylioglu, M., & Lipton, S. A. (2001) · Nature · doi:10.1038/35088074 · Cited by 923
Hydroxylation of HIF-1: Oxygen Sensing at the Molecular Level
Semenza, G. L. (2004) · Physiology · doi:10.1152/physiol.00001.2004 · Cited by 905
Vascular endothelial growth factor in eye disease
Penn, J. S., Madan, A., Caldwell, R. B., Bartoli, M., Caldwell, R. W., & Hartnett, M. E. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.001 · Cited by 762
Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.
Angiolillo, A. L., Sgadari, C., Taub, D. D., Liao, F., Farber, J. M., Maheshwari, S., Kleinman, H. K., Reaman, G. H., & Tosato, G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.155 · Cited by 705
Emerging Multipotent Aspects of Hepatocyte Growth Factor
Matsumoto, K., & Nakamura, T. (1996) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021283 · Cited by 660
Adiponectin: A Novel Adipokine Linking Adipocytes and Vascular Function
Goldstein, B. J., & Scalia, R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0518 · Cited by 647
Goldberg, R. B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2534 · Cited by 644
Regulation of erythropoietin production
Jelkmann, W. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2010.195057 · Cited by 599
Diabetic Macular Edema: Pathogenesis and Treatment
Bhagat, N., Grigorian, R. A., Tutela, A., & Zarbin, M. A. (2009) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2008.10.001 · Cited by 571
Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression
M. Joussen, A., Poulaki, V., Mitsiades, N., Kirchhof, B., Koizumi, K., Döhmen, S., & P. Adamis, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0707fje · Cited by 567
Ribatti, D., Presta, M., Vacca, A., Ria, R., Giuliani, R., Dell’Era, P., Nico, B., Roncali, L., & Dammacco, F. (1999) · Blood · doi:10.1182/blood.v93.8.2627 · Cited by 538
Erythropoietin as a Retinal Angiogenic Factor in Proliferative Diabetic Retinopathy
Watanabe, D., Suzuma, K., Matsui, S., Kurimoto, M., Kiryu, J., Kita, M., Suzuma, I., Ohashi, H., Ojima, T., Murakami, T., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041773 · Cited by 484
Pathophysiology of Diabetic Retinopathy
Tarr, J. M., Kaul, K., Chopra, M., Kohner, E. M., & Chibber, R. (2013) · ISRN Ophthalmology · doi:10.1155/2013/343560 · Cited by 455
Stein, I., Neeman, M., Shweiki, D., Itin, A., & Keshet, E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5363 · Cited by 455
Melder, R. J., Koenig, G. C., Witwer, B. P., Safabakhsh, N., Munn, L. L., & Jain, R. K. (1996) · Nature Medicine · doi:10.1038/nm0996-992 · Cited by 451
Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-κB
Frede, S., Stockmann, C., Freitag, P., & Fandrey, J. (2006) · Biochemical Journal · doi:10.1042/bj20051839 · Cited by 436
Gharaee-Kermani, M., Denholm, E. M., & Phan, S. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17779 · Cited by 435
Ishida, S., Usui, T., Yamashiro, K., Kaji, Y., Amano, S., Ogura, Y., Hida, T., Oguchi, Y., Ambati, J., Miller, J. W., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022027 · Cited by 421
McLeod, D. S., Lefer, D. J., Merges, C., & Lutty, G. A. (1995) · PubMed Central · Cited by 418
CXC chemokines: the regulatory link between inflammation and angiogenesis
Romagnani, P., Lasagni, L., Annunziato, F., Serio, M., & Romagnani, S. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.02.006 · Cited by 409
Aveleira, C. A., Lin, C.-M., Abcouwer, S. F., Ambrósio, A. F., & Antonetti, D. A. (2010) · Diabetes · doi:10.2337/db09-1606 · Cited by 403
Müller Cell-Derived VEGF Is Essential for Diabetes-Induced Retinal Inflammation and Vascular Leakage
Wang, J., Xu, X., Elliott, M. H., Zhu, M., & Le, Y.-Z. (2010) · Diabetes · doi:10.2337/db09-1420 · Cited by 396
Barnes, P. J. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00159-8 · Cited by 395
Tezel, G., & Wax, M. B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08693.2000 · Cited by 395
Stavri, G. T., Zachary, I. C., Baskerville, P. A., Martin, J. F., & Erusalimsky, J. D. (1995) · Circulation · doi:10.1161/01.cir.92.1.11 · Cited by 395
Hong, K. H., Ryu, J., & Han, K. H. (2005) · Blood · doi:10.1182/blood-2004-08-3178 · Cited by 382
Chong, Z. Z., Kang, J.-Q., & Maiese, K. (2002) · Circulation · doi:10.1161/01.cir.0000039103.58920.1f · Cited by 381
Advanced glycation end-products and the progress of diabetic vascular complications.
Jakuš, V, & Rietbrock, N. (2004) · Physiological Research · doi:10.33549/physiolres.930430 · Cited by 341
Is diabetic retinopathy an inflammatory disease?
Adamis, A. P. (2002) · British Journal of Ophthalmology · doi:10.1136/bjo.86.4.363 · Cited by 341
Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?
Blom, I. E., Goldschmeding, R., & Leask, A. (2002) · Matrix Biology · doi:10.1016/s0945-053x(02)00055-0 · Cited by 338
Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice
Sakurai, Y., Ohgimoto, K., Kataoka, Y., Yoshida, N., & Shibuya, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404984102 · Cited by 330
SALCEDO, R., & OPPENHEIM, J. J. (2003) · Microcirculation · doi:10.1038/sj.mn.7800200 · Cited by 328
Erslev, A. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105093241907 · Cited by 327
Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox.
Duh, E., & Aiello, L. P. (1999) · Diabetes · doi:10.2337/diabetes.48.10.1899 · Cited by 319
Erythropoietin and VEGF Exhibit Equal Angiogenic Potential
Jaquet, K., Krause, K., Tawakol-Khodai, M., Geidel, S., & Kuck, K.-H. (2002) · Microvascular Research · doi:10.1006/mvre.2002.2426 · Cited by 317
Pericyte Loss in Diabetic Retinopathy: Mechanisms and Consequences
Beltramo, E., & Porta, M. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990022 · Cited by 317
Funatsu, H., Yamashita, H., Noma, H., Mimura, T., Nakamura, S., Sakata, K., & Hori, S. (2005) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-004-0950-7 · Cited by 312
Vincent, J. A., & Mohr, S. (2007) · Diabetes · doi:10.2337/db06-0427 · Cited by 298
Vascular Endothelial Growth Factor and Its Relationship to Inflammatory Mediators
Angelo, L. S., & Kurzrock, R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2416 · Cited by 295
Doganay, S., Evereklioglu, C., Er, H., Türköz, Y., Sevinç, A., Mehmet, N., & Şavli, H. (2002) · Eye · doi:10.1038/sj.eye.6700095 · Cited by 294
Caldwell, R. B., Bartoli, M., Behzadian, M. A., El‐Remessy, A. E. B., Al‐Shabrawey, M., Platt, D. H., & Caldwell, R. W. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.415 · Cited by 293
Taub, D. D., Anver, M., Oppenheim, J. J., Longo, D. L., & Murphy, W. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118625 · Cited by 281
Morohoshi, M., Fujisawa, K., Uchimuraa, I., & Numano, F. (1996) · Diabetes · doi:10.2337/diab.45.7.954 · Cited by 281
Erythropoietin deficiency decreases vascular stability in mice
Chen, J., Connor, K. M., Aderman, C. M., & Smith, L. E. H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33813 · Cited by 280
Oxygen-dependent diseases in the retina: Role of hypoxia-inducible factors
Arjamaa, O., & Nikinmaa, M. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.01.016 · Cited by 277
Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic.
Ziche, M., Maglione, D., Ribatti, D., Morbidelli, L., Lago, C. T., Battisti, M., Paoletti, I., Barra, A., Tucci, M., Parise, G., et al. (1997) · PubMed · Cited by 277
Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes.
Barouch, F. C., Miyamoto, K., Allport, J. R., Fujita, K., Bursell, S., Aiello, L. P., Luscinskas, F. W., & Adamis, A. P. (2000) · PubMed · Cited by 264
Demonstration of vasoproliferative activity from mammalian retina.
Glaser, B. M., D'Amore, P. A., Michels, R. G., Pätz, A., & Fenselau, A. H. (1980) · The Journal of Cell Biology · doi:10.1083/jcb.84.2.298 · Cited by 264
SDF-1 is both necessary and sufficient to promote proliferative retinopathy
Butler, J. M., Guthrie, S. M., Koc, M., Afzal, A., Caballero, S., Brooks, H. L., Mames, R. N., Segal, M. S., Grant, M. B., & Scott, E. W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522869 · Cited by 263
Localization of Vascular Endothelial Growth Factor in Human Retina and Choroid
Lutty, G. A. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140179011 · Cited by 259
Kiechl, S., Wittmann, J., Giaccari, A., Knoflach, M., Willeit, P., Bozec, A., Moschen, A. R., Muscogiuri, G., Sorice, G. P., Kireva, T., et al. (2013) · Nature Medicine · doi:10.1038/nm.3084 · Cited by 255
Gao, B.-B., Chen, X., Timothy, N., Aiello, L. P., & Feener, E. P. (2008) · Journal of Proteome Research · doi:10.1021/pr800112g · Cited by 249
VEGF increases retinal vascular ICAM-1 expression in vivo.
Lu, M., Perez, V. L., Ma, N., Miyamoto, K., Peng, H., Liao, J. K., & Adamis, A. P. (1999) · PubMed · Cited by 239
Diabetic macular edema: new concepts in patho-physiology and treatment
Zhang, X., Zeng, H., Bao, S., Wang, N., & Gillies, M. C. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-27 · Cited by 230
Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy
Elner, S. G., Elner, V. M., Jaffe, G. J., Stuart, A., Kunkel, S. L., & Strieter, R. M. (1995) · Current Eye Research · doi:10.3109/02713689508998529 · Cited by 228
Role of interleukin-1 in the pathogenesis of diabetic retinopathy
Kowluru, R. A. (2004) · British Journal of Ophthalmology · doi:10.1136/bjo.2003.038133 · Cited by 228
Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications
Frystyk, J., Tarnow, L., Krarup Hansen, T., Parving, H.-H., & Flyvbjerg, A. (2005) · Diabetologia · doi:10.1007/s00125-005-1850-z · Cited by 223
Sivalingam, A. (1990) · Archives of Ophthalmology · doi:10.1001/archopht.1990.01070080113046 · Cited by 218
Huang, H., Gandhi, J. K., Zhong, X., Wei, Y., Gong, J., Duh, E. J., & Vinores, S. A. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5768 · Cited by 215
Cheng, T., Cao, W., Wen, R., Steinberg, R. H., & LaVail, M. M. (1998) · PubMed · Cited by 203
Zong, H., Ward, M., Madden, A., Yong, P. H., Limb, G. A., Curtis, T. M., & Stitt, A. W. (2010) · Diabetologia · doi:10.1007/s00125-010-1900-z · Cited by 201
Microvascular Modifications in Diabetic Retinopathy
Durham, J. T., & Herman, I. M. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0204-0 · Cited by 198
Behl, Y., Krothapalli, P., Desta, T., DiPiazza, A., Roy, S., & Graves, D. T. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071070 · Cited by 197
Roles of IL-8 in Ocular Inflammations: A Review
Ghasemi, H., Ghazanfari, T., Yaraee, R., Faghihzadeh, S., & Hassan, Z. M. (2011) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2011.618902 · Cited by 195
Poulaki, V., Qin, W., Joussen, A. M., Hurlbut, P., Wiegand, S. J., Rudge, J., Yancopoulos, G. D., & Adamis, A. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213776 · Cited by 190
MURUGESWARI, P., SHUKLA, D., RAJENDRAN, A., KIM, R., NAMPERUMALSAMY, P., & MUTHUKKARUPPAN, V. (2008) · Retina · doi:10.1097/iae.0b013e31816576d5 · Cited by 189
Hernández, C., Segura, R. M., Fonollosa, A., Carrasco, E., Francisco, G., & Simó, R. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01538.x · Cited by 188
Targeting inflammation in diabetes: Newer therapeutic options
Agrawal, N. K. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i5.697 · Cited by 186
Inflammation and diabetic retinal microvascular complications
Zhang, W., Liu, H., Al-Shabrawey, M., Caldwell, R. W., & Caldwell, R. B. (2011) · Journal of Cardiovascular Disease Research · doi:10.4103/0975-3583.83035 · Cited by 183
Salicylate-Based Anti-Inflammatory Drugs Inhibit the Early Lesion of Diabetic Retinopathy
Zheng, L., Howell, S. J., Hatala, D. A., Huang, K., & Kern, T. S. (2007) · Diabetes · doi:10.2337/db06-0789 · Cited by 176
CLERMONT, A. C., AIELLO, L. P., MORI, F., AIELLO, L. M., & BURSELL, S.-E. (1997) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70860-8 · Cited by 175
Vascular Endothelial Growth Factor-B in Physiology and Disease
Bry, M., Kivelä, R., Leppänen, V.-M., & Alitalo, K. (2014) · Physiological Reviews · doi:10.1152/physrev.00028.2013 · Cited by 173
The Role of Advanced Glycation End Products in Retinal Microvascular Leukostasis
Moore, T. C. B., Moore, J. E., Kaji, Y., Frizzell, N., Usui, T., Poulaki, V., Campbell, I. L., Stitt, A. W., Gardiner, T. A., Archer, D. B., et al. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1063 · Cited by 172
The role of growth factors in the pathogenesis of diabetic retinopathy
Grant, M. B., Afzal, A., Spoerri, P., Pan, H., Shaw, L. C., & Mames, R. N. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.10.1275 · Cited by 171
Insulin-Like Growth Factor-I Plays a Pathogenetic Role in Diabetic Retinopathy
Poulaki, V., Joussen, A. M., Mitsiades, N., Mitsiades, C. S., Iliaki, E. F., & Adamis, A. P. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63311-1 · Cited by 163
Journal of Clinical & Cellular Immunology
(2019) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899 · Cited by 163
Ayalasomayajula, S. P., & Kompella, U. B. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02793-0 · Cited by 159
Morescalchi, F., Duse, S., Gambicorti, E., Romano, M. R., Costagliola, C., & Semeraro, F. (2013) · Mediators of Inflammation · doi:10.1155/2013/269787 · Cited by 153
Self-citationKaji, Y., Usui, T., Ishida, S., Yamashiro, K., Moore, T., Moore, J. E., Yamamoto, Y., Yamamoto, H., & Adamis, A. P. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0495 · Cited by 153
Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
El‐Asrar, A. M. A., Struyf, S., Kangave, D., Geboes, K. J., & Damme, J. V. (2006) · PubMed · Cited by 152
Yoshida, S., Yoshida, A., & Ishibashi, T. (2004) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-004-0874-2 · Cited by 148
Role of Endothelial Chemokines and Their Receptors during Inflammation
Speyer, C. L., & Ward, P. A. (2011) · Journal of Investigative Surgery · doi:10.3109/08941939.2010.521232 · Cited by 145
Effects of Aspirin Treatment on Diabetic Retionopathy
* (1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38010-5 · Cited by 145
Hernández, C., Fonollosa, A., García‐Ramírez, M., Higuera, M., Catalán, R., Miralles, A., García‐Arumí, J., & Simó, R. (2006) · Diabetes Care · doi:10.2337/dc06-0556 · Cited by 141
Behl, Y., Krothapalli, P., Desta, T., Roy, S., & Graves, D. T. (2009) · Diabetes · doi:10.2337/db08-0537 · Cited by 140
Semenza, G. L. (1994) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30134-5 · Cited by 135
Increased expression of placenta growth factor in proliferative diabetic retinopathy.
Khaliq, A., Foreman, D., Ahmed, A., Weich, H. A., Gregor, Z. J., McLeod, D., & Boulton, M. E. (1998) · PubMed · Cited by 134
Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells
Canfield, A. E., & Schor, A. M. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.2.797 · Cited by 132
Gubitosi‐Klug, R., Talahalli, R. R., Du, Y., Nadler, J. L., & Kern, T. S. (2008) · Diabetes · doi:10.2337/db07-1217 · Cited by 131
Harada, C., Harada, T., Quah, H.-M. A., Maekawa, F., Yoshida, K., Ohno, S., Wada, K., Parada, L. F., & Tanaka, K. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00599-2 · Cited by 130
Osteopontin (Eta-1) and Fibroblast Growth Factor-2 Cross-Talk in Angiogenesis
Leali, D., Dell’Era, P., Stabile, H., Sennino, B., Chambers, A. F., Naldini, A., Sozzani, S., Nico, B., Ribatti, D., & Presta, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.1085 · Cited by 126
Hernández, C., Burgos, R., Cantón, A., García‐Arumí, J., Segura, R., & Simó, R. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.516 · Cited by 121
Treins, C., Giorgetti‐Peraldi, S., Murdaca, J., Monthouel, M.-N., & OBBERGHEN, E. V. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0239 · Cited by 120
Sone, H., Kawakami, Y., Okuda, Y., Kondo, S., Hanatani, M., Suzuki, H., & Yamashita, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0568 · Cited by 118
TNF-Alpha Levels in Tears: A Novel Biomarker to Assess the Degree of Diabetic Retinopathy
Costagliola, C., Romano, V., Tollis, M. D., Aceto, F., dell’Omo, R., Romano, M. R., Pedicino, C., & Semeraro, F. (2013) · Mediators of Inflammation · doi:10.1155/2013/629529 · Cited by 115
Self-citationEsser, P., Heimann, K., & Wiedemann, P. (1993) · British Journal of Ophthalmology · doi:10.1136/bjo.77.11.731 · Cited by 114
Regulation of inflammasome activity
Guarda, G., & So, A. K.-L. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03283.x · Cited by 112
El‐Asrar, A. M. A., Nawaz, M. I., Kangave, D., Geboes, K. J., Ola, M. S., Ahmad, S., & Al‐Shabrawey, M. (2011) · PubMed Central · Cited by 111
Expression of Erythropoietin and Its Receptor in the Human Retina
García‐Ramírez, M., Hernández, C., & Simó, R. (2008) · Diabetes Care · doi:10.2337/dc07-2075 · Cited by 111
Burgos, R., Mateo, C., Cantón, A., Hernández, C., Mesa, J., & Simó, R. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.80 · Cited by 109
Chen, Y.-S., Hackett, S. F., Schoenfeld, C., Vinores, M. A., Vinores, S. A., & Campochiaro, P. A. (1997) · British Journal of Ophthalmology · doi:10.1136/bjo.81.10.919 · Cited by 106
Oh, I. K., Kim, S., Oh, J., Lee, T. S., & Huh, K. (2010) · Current Eye Research · doi:10.3109/02713683.2010.510257 · Cited by 105
Hiratsuka, S., Kataoka, Y., Nakao, K., Nakamura, K., Morikawa, S., Tanaka, S., Katsuki, M., Maru, Y., & Shibuya, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.355-363.2005 · Cited by 103
Majka, S. M., McGuire, P. G., & Das, A. (2002) · PubMed · Cited by 97
Schwartzman, M. L., Iserovich, P., Gotlinger, K. H., Bellner, L., Dunn, M. W., Sartore, M., Pertile, G., Leonardi, A., Sathe, S., Beaton, A. R., et al. (2010) · Diabetes · doi:10.2337/db10-0110 · Cited by 97
Cutting Edge: IL-1β Mediates the Proangiogenic Activity of Osteopontin-Activated Human Monocytes
Naldini, A., Leali, D., Pucci, A., Morena, E., Carraro, F., Nico, B., Ribatti, D., & Presta, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4267 · Cited by 96
Usefulness of the Vitreous Fluid Analysis in the Translational Research of Diabetic Retinopathy
Simó‐Servat, O., Hernández, C., & Simó, R. (2012) · Mediators of Inflammation · doi:10.1155/2012/872978 · Cited by 94
Microvascular complications and diabetic retinopathy: recent advances and future implications
Barot, M., Gokulgandhi, M. R., Patel, S., & Mitra, A. K. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.12.206 · Cited by 92
Katsura, Y., Okano, T., Matsuno, K., Osako, M., Kure, M., Watanabe, T., Iwaki, Y., Noritake, M., Kosano, H., Nishigori, H., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2252 · Cited by 92
Adamiec-Mroczek, J., Oficjalska−Młyńczak, J., & Misiuk‐Hojło, M. (2009) · Cytokine · doi:10.1016/j.cyto.2009.11.004 · Cited by 91
Monocyte Chemotactic Protein-1 in the Vitreous of Patients with Proliferative Diabetic Retinopathy
Mitamura, Y., Takeuchi, S., Matsuda, A., Tagawa, Y., Mizue, Y., & Nishihira, J. (2001) · Ophthalmologica · doi:10.1159/000050900 · Cited by 90
Erythropoietin — An Endogenous Retinal Survival Factor
Becerra, S. P., & Amaral, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmcibr022629 · Cited by 89
Zijlstra, A., Seandel, M., Kupriyanova, T. A., Partridge, J. J., Madsen, M. A., Hahn-Dantona, E. A., Quigley, J. P., & Deryugina, E. I. (2005) · Blood · doi:10.1182/blood-2005-04-1458 · Cited by 86
Gologorsky, D., Thanos, A., & Vavvas, D. G. (2012) · Mediators of Inflammation · doi:10.1155/2012/629452 · Cited by 84
Aplin, A. C., Gelati, M., Fogel, E., Carnevale, E., & Nicosia, R. F. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00048.2006 · Cited by 81
Role of Inflammation in Diabetic Macular Edema
Noma, H., Mimura, T., Yasuda, K., & Shimura, M. (2014) · Ophthalmologica · doi:10.1159/000364955 · Cited by 81
Adiponectin may play a part in the pathogenesis of diabetic retinopathy
Yilmaz, M., Sönmez, A., Açıkel, C., Celık, T., Bingöl, N., Pinar, M., Bayraktar, Z., & Özata, M. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510135 · Cited by 72
El‐Asrar, A. M. A., Missotten, L., & Geboes, K. J. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.109876 · Cited by 71
Shinoda, K., Ishida, S., Kawashima, S., Wakabayashi, T., Matsuzaki, T., Takayama, M., Shinmura, K., & Yamada, M. (1999) · British Journal of Ophthalmology · doi:10.1136/bjo.83.7.834 · Cited by 70
Vitreous Mediators in Retinal Hypoxic Diseases
dell’Omo, R., Semeraro, F., Bamonte, G., Cifariello, F., Romano, M. R., & Costagliola, C. (2013) · Mediators of Inflammation · doi:10.1155/2013/935301 · Cited by 68
Self-citationNakao, S., Arima, M., Ishikawa, K., Kohno, R.-I., Kawahara, S., Miyazaki, M., Yoshida, S., Enaida, H., Hafezi‐Moghadam, A., Kono, T., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-9119 · Cited by 68
Growth Factors in Proliferative Diabetic Retinopathy
Khan, Z. A., & Chakrabarti, S. (2003) · Journal of Diabetes Research · doi:10.1155/edr.2003.287 · Cited by 66
Tumor necrosis factor-alpha (TNF-α)-induced optic neuropathy in rabbits
Madigan, M. C., Sadun, A. A., Rao, N. S., Dugel, P. U., Tenhula, W. N., & Gill, P. S. (1996) · Neurological Research · doi:10.1080/01616412.1996.11740399 · Cited by 66
Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
Cai, W., Rook, S. L., Jiang, Z. Y., Takahara, N., & Aiello, L. P. (2000) · PubMed · Cited by 65
Sakai, N., Sweringen, H. L. V., Schuster, R. M., Blanchard, J. A., Burns, J. M., Tevar, A. D., Edwards, M. J., & Lentsch, A. B. (2011) · Hepatology · doi:10.1002/hep.24756 · Cited by 64
Matsunaga, N., Chikaraishi, Y., Izuta, H., Ogata, N., Shimazawa, M., Matsumura, M., & Hara, H. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.06.025 · Cited by 63
Costagliola, C. (1990) · PubMed · Cited by 61
Self-citationIntraocular expression and release of high-mobility group box 1 protein in retinal detachment
Arimura, N., Kii, Y., Hashiguchi, T., Kawahara, K., Biswas, K. K., Nakamura, M., Sonoda, Y., Yamakiri, K., Okubo, A., Sakamoto, T., et al. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2008.165 · Cited by 58
Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy
Canton, A. (2000) · British Journal of Ophthalmology · doi:10.1136/bjo.84.7.732 · Cited by 57
Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit
Wong, C. G., Rich, K. A., Liaw, L. L., Hsu, H. T., & Berns, M. W. (2001) · Current Eye Research · doi:10.1076/ceyr.22.2.140.5528 · Cited by 55
Role of Cytokines and Trophic Factors in the Pathogenesis of Diabetic Retinopathy
Mitamura, Y., Harada, C., & Harada, T. (2005) · Current Diabetes Reviews · doi:10.2174/1573399052952596 · Cited by 50
Functional Characteristics of Connective Tissue Growth Factor on Vitreoretinal Cells
Kita, T., Hata, Y., Miura, M., Kawahara, S., Nakao, S., & Ishibashi, T. (2007) · Diabetes · doi:10.2337/db06-1644 · Cited by 49
Fractalkine, a CX3C Chemokine, as a Mediator of Ocular Angiogenesis
You, J.-J., Yang, C., Huang, J.-S., Chen, M., & Yang, C. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0187 · Cited by 47
Stahl, A., Buchwald, A., Martin, G., Junker, B., Chen, J., Hansen, L. L., Agostini, H. T., Smith, L. E. H., & Feltgen, N. (2010) · Retina · doi:10.1097/iae.0b013e3181d37539 · Cited by 45
Monte, M. D., Rezzola, S., Cammalleri, M., Belleri, M., Locri, F., Morbidelli, L., Corsini, M., Paganini, G., Semeraro, F., Cancarini, A., et al. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-16323 · Cited by 45
Self-citationLandmark advances in the development of erythropoietin
Fisher, J. W. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.010137 · Cited by 44
Semeraro, F., Cancarini, A., Morescalchi, F., Romano, M. R., dell’Omo, R., Ruggeri, G., Agnifili, L., & Costagliola, C. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.04.005 · Cited by 44
Self-citationLee, J., Hsiao, C., Yang, I.-H., Chou, M.-H., Wu, C., Wei, Y.-C., Chen, C.-H., & Chuang, J. (2012) · PubMed Central · Cited by 44
Dull, R. O., Yuan, J., Chang, Y. S., Tarbell, J. M., Jain, R. K., & Munn, L. L. (2001) · Microvascular Research · doi:10.1006/mvre.2000.2298 · Cited by 41
Costagliola, C., Daniele, A., dell’Omo, R., Romano, M. R., Aceto, F., Agnifili, L., Semeraro, F., & Porcellini, A. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.02.004 · Cited by 39
Self-citationHigh Mobility Group Box Protein-1 in Experimental Autoimmune Uveoretinitis
Watanabe, T., Keino, H., Sato, Y., Kudo, A., Kawakami, H., & Okada, A. A. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2709 · Cited by 31
Immunohistochemical demonstration of cellular fibronectin and tenascin in human epiretinal membranes
Immonen, I. J. R., Laatikainen, L., Tervo, T., Tervo, K., & Virtanen, I. (1991) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.1991.tb02024.x · Cited by 31
Glial cell expression of hepatocyte growth factor in vitreoretinal proliferative disease
Hollborn, M., Krausse, C., Iandiev, I., et al. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700121 · Cited by 29
Rezzola, S., Monte, M. D., Belleri, M., Bugatti, A., Chiodelli, P., Corsini, M., Cammalleri, M., Cancarini, A., Morbidelli, L., Oreste, P., et al. (2015) · Diabetes · doi:10.2337/db14-1378 · Cited by 24
Self-citationErythropoietin: when liability becomes asset in neurovascular repair
Grant, M. B., Boulton, M. E., & Ljubimov, A. V. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34643 · Cited by 23
Arjamaa, O., Pöllönen, M., Kinnunen, K., Ryhänen, T., & Kaarniranta, K. (2011) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2011.06.002 · Cited by 21
Wakabayashi, Y., Usui, Y., Okunuki, Y., Takeuchi, M., Kezuka, T., Iwasaki, T., & Gotô, H. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02466.x · Cited by 21
Cells expressing the stem cell factor receptor, c-kit, contribute to neoangiogenesis in diabetes
Kelly, D. J., Zhang, Y., Gow, R. M., Itescu, S., & Gilbert, R. E. (2005) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2005.013 · Cited by 17
High glucose stimulates the expression of erythropoietin in rat glomerular epithelial cells
Lim, S. K., & Park, S. H. (2011) · Laboratory Animal Research · doi:10.5625/lar.2011.27.3.245 · Cited by 15
Poulaki, V., Qin, W., Joussen, A. M., Hurlbut, P., Wiegand, S. J., Rudge, J. S., Yancopoulos, G. D., & Adamis, A. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200213776 · Cited by 14
Erythropoietin and Diabetic Retinopathy
Semeraro, F. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000283 · Cited by 7
Self-citation
Cited by
Altmann, C., & Schmidt, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010110 · Cited by 402
Microglia and Inflammatory Responses in Diabetic Retinopathy
Kinuthia, U. M., Wolf, A., & Langmann, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.564077 · Cited by 321
Angiogenesis and Inflammation Crosstalk in Diabetic Retinopathy
Capitão, M., & Soares, R. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25575 · Cited by 312
Biomarkers in Diabetic Retinopathy
Jenkins, A. J., Joglekar, M. V., Hardikar, A. A., Keech, A. C., O'Neal, D. N., & Januszewski, A. S. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.159 · Cited by 296
Xu, G.-T., Zhang, J.-F., & Tang, L. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.355743 · Cited by 280
Metadata
- Authors
- Semeraro, F., Cancarini, A., dell’Omo, R., Rezzola, S., Romano, M. R., & Costagliola, C.
- Venue
- Journal of Diabetes Research
- Publisher
- Hindawi Limited
- Published
- 2015
- Volume
- 2015
- Pages
- 1-16
- ISSN
- 2314-6745 (ISSN-L)
- 2314-6753
- OpenAlex
- W1518103124
- Cited by
- 424
- References
- 176
- FWCI
- 33.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.